glp 1 mash approval Novo's Wegovy becomes first GLP-1 drug approved for GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT

-Ralph Waldo Emerson *Notice: The trademarked pharmaceuticals such as, Saxenda, Victoza, Wegovy, and Ozempic are solely distributed by Novo Nordisk

Bidens nursing home rule would cost $17 billion and lead to facilities closing down

But there is a flip side worth knowing about

The observed mean change in BMI SDS from baseline to Week 56 was -0.23 in the SAXENDA group and -0.00 in the placebo group

In the longer term, however, reduced obesity rates among Medicaid enrollees could also result in reduced Medicaid spending on chronic diseases associated with obesity, such as heart disease, type 2 diabetes and types of cancer, the researchers noted in a KFF news release

But behind the hype, researchers in the burgeoning field of geroscience which seeks to understand the biology of aging have been investigating whether GLP-1 drugs like Ozempic and Zepbound do more than treat obesity and diabetes